Richard Mott Biography and Net Worth

Richard W. Mott is the founder of Accendo Therapeutics, Inc. Current jobs include Executive Chairman at Endologix LLC since 2021, Chairman at Arsenal Medical, Inc., Chairman at Relievant Medsystems, Inc., Chairman at Conventus Orthopaedics, Inc. since 2017, Chairman at CeQur SA, Director at TriVascular, Inc., Director at Vertiflex, Inc. since 2018, Lead Independent Director at Treace Medical Concepts, Inc. since 2015, Principal at Walkabout Consulting LLC since 2009, and Advisor at Vensana Capital Management LLC since 2020.
Former jobs include President & Chief Executive Officer at Medtronic Spine LLC from 2002 to 2007, President, Chief Executive Officer & Director at Kyphon, Inc. from 2002 to 2007, Chairman at PhotoThera, Inc., Chairman at Silk Road Medical, Inc. from 2014 to 2017, Director at Microchips Biotech, Inc. in 2014, Director & Owner at VfD Technologies, Inc. from 2010 to 2021, Chief Operating Officer at Bristol Myers Squibb Co., and Chief Operating Officer at Integer Holdings Corp.
from 1998 to 2002.
Education includes an undergraduate degree from Alfred University.

What is Richard W. Mott's net worth?: The estimated net worth of Richard W. Mott is at least $2.89 million as of May 22nd, 2024. Mr. Mott owns 1,054,944 shares of Treace Medical Concepts stock worth more than $2,890,547 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Mott may own. Learn More about Richard W. Mott's net worth.
How do I contact Richard W. Mott?: The corporate mailing address for Mr. Mott and other Treace Medical Concepts executives is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. Treace Medical Concepts can also be reached via phone at 904-373-5940 and via email at [email protected]. Learn More on Richard W. Mott's contact information.
Has Richard W. Mott been buying or selling shares of Treace Medical Concepts?: Richard W. Mott has not been actively trading shares of Treace Medical Concepts during the last ninety days. Most recently, on Wednesday, May 22nd, Richard W. Mott bought 12,100 shares of Treace Medical Concepts stock. The stock was acquired at an average cost of $4.99 per share, with a total value of $60,379.00. Following the completion of the transaction, the director now directly owns 1,054,944 shares of the company's stock, valued at $5,264,170.56. Learn More on Richard W. Mott's trading history.
Who are Treace Medical Concepts' active insiders?: Treace Medical Concepts' insider roster includes Deepti Jain (Director), Richard Mott (Director), Sean Scanlan (SVP), Thomas Timbie (Director), James Treace (Director), John Treace (CEO), and John Treace (Director). Learn More on Treace Medical Concepts' active insiders.
Are insiders buying or selling shares of Treace Medical Concepts?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 50,000 shares worth more than $398,500.00. The most recent insider tranaction occured on March, 17th when insider Sean F Scanlan sold 50,000 shares worth more than $398,500.00. Insiders at Treace Medical Concepts own 27.7% of the company. Learn More about insider trades at Treace Medical Concepts.
Information on this page was last updated on 3/17/2025.

Richard W. Mott Insider Trading History at Treace Medical Concepts

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/22/2024	Buy	12,100	$4.99	$60,379.00	1,054,944
5/13/2024	Buy	36,802	$4.38	$161,192.76	1,027,753
4/6/2023	Sell	4,043	$26.00	$105,118.00	905,000
4/3/2023	Sell	201	$26.00	$5,226.00	924,799
3/30/2023	Sell	38,498	$26.00	$1,000,948.00	1,020,000
3/8/2023	Sell	45,000	$23.17	$1,042,650.00	1,060,000
2/2/2023	Sell	4,011	$24.00	$96,264.00	1,155,000
1/17/2023	Sell	11,014	$26.00	$286,364.00	1,250,000
1/12/2023	Sell	42,467	$26.00	$1,104,142.00	1,267,533
1/9/2023	Sell	10,444	$24.00	$250,656.00	1,310,000
1/5/2023	Sell	9,556	$24.00	$229,344.00	1,320,444
12/30/2022	Sell	75,000	$22.67	$1,700,250.00	1,330,000
11/30/2022	Sell	75,000	$21.90	$1,642,500.00	1,425,000
10/31/2022	Sell	95,000	$23.57	$2,239,150.00	1,500,000

Richard W. Mott Buying and Selling Activity at Treace Medical Concepts

Treace Medical Concepts Company Overview

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Today's Range

Now: $2.74

$2.65

$2.79

50 Day Range

MA: $5.08

$2.61

$6.95

2 Week Range

Now: $2.74

$2.56

$10.79

Volume

733,622 shs

Average Volume

1,250,454 shs

Market Capitalization

$174.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73